PURPOSE: Vesicular monoamine transporter type 2 abundance quantified using the radiotracer [(11)C]-dihydrotetrabenazine (DTBZ) has been used to study diagnosis and pathogenesis of dementia and psychiatric disorders in humans. In addition, it may be a surrogate marker for insulin-producing pancreatic beta cell mass, useful for longitudinal measurements using positron emission tomography to track progression of autoimmune diabetes. To support the feasibility of long-term repeated administrations, we estimate the biodistribution and dosimetry of [(11)C]-DTBZ in humans. METHODS: Five baboon studies were acquired using a Siemens ECAT camera. After transmission scanning, 165-210 MBq of [(11)C]-DTBZ were injected, and dynamic whole body emission scans were conducted. Time-activity data were used to obtain residence times and estimate absorbed radiation dose according to the MIRD model. RESULTS: Most of the injected tracer localized to the liver and the lungs, followed by the intestines, brain, and kidneys. The highest estimated absorbed radiation dose was in the stomach wall. CONCLUSIONS: The largest radiation dose from [(11)C]-DTBZ is to the stomach wall. This dose estimate, as well as the radiation dose to other radiosensitive organs, must be considered in evaluating the risks of multiple administrations.
PURPOSE: Vesicular monoamine transporter type 2 abundance quantified using the radiotracer [(11)C]-dihydrotetrabenazine (DTBZ) has been used to study diagnosis and pathogenesis of dementia and psychiatric disorders in humans. In addition, it may be a surrogate marker for insulin-producing pancreatic beta cell mass, useful for longitudinal measurements using positron emission tomography to track progression of autoimmune diabetes. To support the feasibility of long-term repeated administrations, we estimate the biodistribution and dosimetry of [(11)C]-DTBZ in humans. METHODS: Five baboon studies were acquired using a Siemens ECAT camera. After transmission scanning, 165-210 MBq of [(11)C]-DTBZ were injected, and dynamic whole body emission scans were conducted. Time-activity data were used to obtain residence times and estimate absorbed radiation dose according to the MIRD model. RESULTS: Most of the injected tracer localized to the liver and the lungs, followed by the intestines, brain, and kidneys. The highest estimated absorbed radiation dose was in the stomach wall. CONCLUSIONS: The largest radiation dose from [(11)C]-DTBZ is to the stomach wall. This dose estimate, as well as the radiation dose to other radiosensitive organs, must be considered in evaluating the risks of multiple administrations.
Authors: Matthew S Milak; R Todd Ogden; Daniel N Vinocur; Ronald L Van Heertum; Thomas B Cooper; J John Mann; Ramin V Parsey Journal: Biol Psychiatry Date: 2005-01-01 Impact factor: 13.382
Authors: Marie-José Bélanger; Norman R Simpson; Theodore Wang; Ronald L Van Heertum; J John Mann; Ramin V Parsey Journal: Nucl Med Biol Date: 2004-11 Impact factor: 2.408
Authors: Evan L Riddle; Matthew K Topham; John W Haycock; Glen R Hanson; Annette E Fleckenstein Journal: Eur J Pharmacol Date: 2002-08-02 Impact factor: 4.432
Authors: S Lehéricy; J P Brandel; E C Hirsch; P Anglade; J Villares; D Scherman; C Duyckaerts; F Javoy-Agid; Y Agid Journal: Brain Res Date: 1994-10-03 Impact factor: 3.252
Authors: D Flamez; I Roland; A Berton; B Kutlu; D Dufrane; M C Beckers; E De Waele; I Rooman; L Bouwens; A Clark; M Lonneux; J F Jamar; S Goldman; D Maréchal; N Goodman; P Gianello; C Van Huffel; I Salmon; D L Eizirik Journal: Diabetologia Date: 2010-04-09 Impact factor: 10.122
Authors: Yuli Xie; Anthony Raffo; Masanori Ichise; Shixian Deng; Paul E Harris; Donald W Landry Journal: Bioorg Med Chem Lett Date: 2008-08-07 Impact factor: 2.823
Authors: Reinier Hernandez; Stephen A Graves; Trillian Gregg; Halena R VanDeusen; Rachel J Fenske; Haley N Wienkes; Christopher G England; Hector F Valdovinos; Justin J Jeffery; Todd E Barnhart; Gregory W Severin; Robert J Nickles; Michelle E Kimple; Matthew J Merrins; Weibo Cai Journal: Diabetes Date: 2017-05-17 Impact factor: 9.461